Review



camptothecin cpt compounds  (MedChemExpress)


Bioz Verified Symbol MedChemExpress is a verified supplier
Bioz Manufacturer Symbol MedChemExpress manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    MedChemExpress camptothecin cpt compounds
    FLI1 expression in HaCaT cells induces a spectrum of genes associated with psoriasis. ( a ) The Kegg pathway enrichment analysis of DEGs identified in HaCaT-FLI1 versus HaCaT-control cells. ( b ) The left panel shows the heatmap of DEGs with significant differences derived from HaCaT-FLI1 versus HaCaT-control cells. The right panel presents the FPKM scores of the indicated genes. ( c ) Relative expression of the indicated genes in the HaCaT-FLI1 and HaCaT-control cells, as determined by RT-qPCR. ( d ) The expression analysis of FLI1 in HaCaT-FLI1 cells treated with either DMSO or 20 nM of <t>Camptothecin</t> <t>(CPT)</t> for 24h, as determined by Western blotting. P ≤0.01 (**), P ≤0.001 (***) and P ≤0.0001 (****).
    Camptothecin Cpt Compounds, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 29 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/camptothecin cpt compounds/product/MedChemExpress
    Average 94 stars, based on 29 article reviews
    camptothecin cpt compounds - by Bioz Stars, 2026-02
    94/100 stars

    Images

    1) Product Images from "FLI1 Induces Plaque Psoriasis and Its Inhibition Attenuates Disease Progression"

    Article Title: FLI1 Induces Plaque Psoriasis and Its Inhibition Attenuates Disease Progression

    Journal: Journal of Inflammation Research

    doi: 10.2147/JIR.S500822

    FLI1 expression in HaCaT cells induces a spectrum of genes associated with psoriasis. ( a ) The Kegg pathway enrichment analysis of DEGs identified in HaCaT-FLI1 versus HaCaT-control cells. ( b ) The left panel shows the heatmap of DEGs with significant differences derived from HaCaT-FLI1 versus HaCaT-control cells. The right panel presents the FPKM scores of the indicated genes. ( c ) Relative expression of the indicated genes in the HaCaT-FLI1 and HaCaT-control cells, as determined by RT-qPCR. ( d ) The expression analysis of FLI1 in HaCaT-FLI1 cells treated with either DMSO or 20 nM of Camptothecin (CPT) for 24h, as determined by Western blotting. P ≤0.01 (**), P ≤0.001 (***) and P ≤0.0001 (****).
    Figure Legend Snippet: FLI1 expression in HaCaT cells induces a spectrum of genes associated with psoriasis. ( a ) The Kegg pathway enrichment analysis of DEGs identified in HaCaT-FLI1 versus HaCaT-control cells. ( b ) The left panel shows the heatmap of DEGs with significant differences derived from HaCaT-FLI1 versus HaCaT-control cells. The right panel presents the FPKM scores of the indicated genes. ( c ) Relative expression of the indicated genes in the HaCaT-FLI1 and HaCaT-control cells, as determined by RT-qPCR. ( d ) The expression analysis of FLI1 in HaCaT-FLI1 cells treated with either DMSO or 20 nM of Camptothecin (CPT) for 24h, as determined by Western blotting. P ≤0.01 (**), P ≤0.001 (***) and P ≤0.0001 (****).

    Techniques Used: Expressing, Control, Derivative Assay, Quantitative RT-PCR, Western Blot



    Similar Products

    camptothecin cpt compounds  (MedChemExpress)
    94
    MedChemExpress camptothecin cpt compounds
    FLI1 expression in HaCaT cells induces a spectrum of genes associated with psoriasis. ( a ) The Kegg pathway enrichment analysis of DEGs identified in HaCaT-FLI1 versus HaCaT-control cells. ( b ) The left panel shows the heatmap of DEGs with significant differences derived from HaCaT-FLI1 versus HaCaT-control cells. The right panel presents the FPKM scores of the indicated genes. ( c ) Relative expression of the indicated genes in the HaCaT-FLI1 and HaCaT-control cells, as determined by RT-qPCR. ( d ) The expression analysis of FLI1 in HaCaT-FLI1 cells treated with either DMSO or 20 nM of <t>Camptothecin</t> <t>(CPT)</t> for 24h, as determined by Western blotting. P ≤0.01 (**), P ≤0.001 (***) and P ≤0.0001 (****).
    Camptothecin Cpt Compounds, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/camptothecin cpt compounds/product/MedChemExpress
    Average 94 stars, based on 1 article reviews
    camptothecin cpt compounds - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    chemical compound, drug camptothecin (cpt)  (Millipore)
    90
    Millipore chemical compound, drug camptothecin (cpt)
    FLI1 expression in HaCaT cells induces a spectrum of genes associated with psoriasis. ( a ) The Kegg pathway enrichment analysis of DEGs identified in HaCaT-FLI1 versus HaCaT-control cells. ( b ) The left panel shows the heatmap of DEGs with significant differences derived from HaCaT-FLI1 versus HaCaT-control cells. The right panel presents the FPKM scores of the indicated genes. ( c ) Relative expression of the indicated genes in the HaCaT-FLI1 and HaCaT-control cells, as determined by RT-qPCR. ( d ) The expression analysis of FLI1 in HaCaT-FLI1 cells treated with either DMSO or 20 nM of <t>Camptothecin</t> <t>(CPT)</t> for 24h, as determined by Western blotting. P ≤0.01 (**), P ≤0.001 (***) and P ≤0.0001 (****).
    Chemical Compound, Drug Camptothecin (Cpt), supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/chemical compound, drug camptothecin (cpt)/product/Millipore
    Average 90 stars, based on 1 article reviews
    chemical compound, drug camptothecin (cpt) - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    FLI1 expression in HaCaT cells induces a spectrum of genes associated with psoriasis. ( a ) The Kegg pathway enrichment analysis of DEGs identified in HaCaT-FLI1 versus HaCaT-control cells. ( b ) The left panel shows the heatmap of DEGs with significant differences derived from HaCaT-FLI1 versus HaCaT-control cells. The right panel presents the FPKM scores of the indicated genes. ( c ) Relative expression of the indicated genes in the HaCaT-FLI1 and HaCaT-control cells, as determined by RT-qPCR. ( d ) The expression analysis of FLI1 in HaCaT-FLI1 cells treated with either DMSO or 20 nM of Camptothecin (CPT) for 24h, as determined by Western blotting. P ≤0.01 (**), P ≤0.001 (***) and P ≤0.0001 (****).

    Journal: Journal of Inflammation Research

    Article Title: FLI1 Induces Plaque Psoriasis and Its Inhibition Attenuates Disease Progression

    doi: 10.2147/JIR.S500822

    Figure Lengend Snippet: FLI1 expression in HaCaT cells induces a spectrum of genes associated with psoriasis. ( a ) The Kegg pathway enrichment analysis of DEGs identified in HaCaT-FLI1 versus HaCaT-control cells. ( b ) The left panel shows the heatmap of DEGs with significant differences derived from HaCaT-FLI1 versus HaCaT-control cells. The right panel presents the FPKM scores of the indicated genes. ( c ) Relative expression of the indicated genes in the HaCaT-FLI1 and HaCaT-control cells, as determined by RT-qPCR. ( d ) The expression analysis of FLI1 in HaCaT-FLI1 cells treated with either DMSO or 20 nM of Camptothecin (CPT) for 24h, as determined by Western blotting. P ≤0.01 (**), P ≤0.001 (***) and P ≤0.0001 (****).

    Article Snippet: Chelerythrine, IMQ, TPA and Camptothecin (CPT) compounds were obtained from MCE (MCE, CN).

    Techniques: Expressing, Control, Derivative Assay, Quantitative RT-PCR, Western Blot